Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Therapeutic Nuclear Medicines Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Therapeutic Nuclear Medicines Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Therapeutic Nuclear Medicines Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Therapeutic Nuclear Medicines Market-Segmentation by Type 5.1 Beta Emitters 5.2 Alpha Emitters 5.3 Brachytherapy Products 6 Global Therapeutic Nuclear Medicines Market-Segmentation by Application 6.1 Hospitals 6.2 Ambulatory Surgical Centers 6.3 Radiology Clinics 7 Global Therapeutic Nuclear Medicines Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Advanced Accelerator Applications S.A. 8.1.1 Advanced Accelerator Applications S.A. Profile 8.1.2 Advanced Accelerator Applications S.A. Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Advanced Accelerator Applications S.A. Product/Solution Launches and Enhancements Analysis 8.1.4 Advanced Accelerator Applications S.A. Business Overview/Recent Development/Acquisitions 8.2 Nordion, Inc. 8.2.1 Nordion, Inc. Profile 8.2.2 Nordion, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Nordion, Inc. Product/Solution Launches and Enhancements Analysis 8.2.4 Nordion, Inc. Business Overview/Recent Development/Acquisitions 8.3 Eczacibasi-Monrol Nuclear Products 8.3.1 Eczacibasi-Monrol Nuclear Products Profile 8.3.2 Eczacibasi-Monrol Nuclear Products Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Eczacibasi-Monrol Nuclear Products Product/Solution Launches and Enhancements Analysis 8.3.4 Eczacibasi-Monrol Nuclear Products Business Overview/Recent Development/Acquisitions 8.4 Bayer AG 8.4.1 Bayer AG Profile 8.4.2 Bayer AG Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Bayer AG Product/Solution Launches and Enhancements Analysis 8.4.4 Bayer AG Business Overview/Recent Development/Acquisitions 8.5 GE Healthcare 8.5.1 GE Healthcare Profile 8.5.2 GE Healthcare Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 GE Healthcare Product/Solution Launches and Enhancements Analysis 8.5.4 GE Healthcare Business Overview/Recent Development/Acquisitions 8.6 Cardinal Health Inc. 8.6.1 Cardinal Health Inc. Profile 8.6.2 Cardinal Health Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Cardinal Health Inc. Product/Solution Launches and Enhancements Analysis 8.6.4 Cardinal Health Inc. Business Overview/Recent Development/Acquisitions 8.7 Bracco Imaging S.p.A 8.7.1 Bracco Imaging S.p.A Profile 8.7.2 Bracco Imaging S.p.A Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Bracco Imaging S.p.A Product/Solution Launches and Enhancements Analysis 8.7.4 Bracco Imaging S.p.A Business Overview/Recent Development/Acquisitions 8.8 Mallinckrodt plc. 8.8.1 Mallinckrodt plc. Profile 8.8.2 Mallinckrodt plc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Mallinckrodt plc. Product/Solution Launches and Enhancements Analysis 8.8.4 Mallinckrodt plc. Business Overview/Recent Development/Acquisitions 8.9 IBA Molecular Imaging 8.9.1 IBA Molecular Imaging Profile 8.9.2 IBA Molecular Imaging Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 IBA Molecular Imaging Product/Solution Launches and Enhancements Analysis 8.9.4 IBA Molecular Imaging Business Overview/Recent Development/Acquisitions 8.10 Lantheus Medical Imaging Inc. 8.10.1 Lantheus Medical Imaging Inc. Profile 8.10.2 Lantheus Medical Imaging Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Lantheus Medical Imaging Inc. Product/Solution Launches and Enhancements Analysis 8.10.4 Lantheus Medical Imaging Inc. Business Overview/Recent Development/Acquisitions 9 Global Therapeutic Nuclear Medicines Market-Segmentation by Geography 10 North America 10.1 North America Therapeutic Nuclear Medicines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Therapeutic Nuclear Medicines Production Analysis from 2014-2019E 10.4 North America Therapeutic Nuclear Medicines Consumption Analysis from 2014-2019E 10.5 North America Therapeutic Nuclear Medicines Import and Export from 2014-2019E 10.6 North America Therapeutic Nuclear Medicines Value, Production and Market Share by Type (2014-2019E) 10.7 North America Therapeutic Nuclear Medicines Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Therapeutic Nuclear Medicines by Country (United States, Canada) 10.8.1 North America Therapeutic Nuclear Medicines Sales by Country (2014-2019E) 10.8.2 North America Therapeutic Nuclear Medicines Consumption Value by Country (2014-2019E) 10.9 North America Therapeutic Nuclear Medicines Market PEST Analysis 11 Europe 11.1 Europe Therapeutic Nuclear Medicines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Therapeutic Nuclear Medicines Production Analysis from 2014-2019E 11.4 Europe Therapeutic Nuclear Medicines Consumption Analysis from 2014-2019E 11.5 Europe Therapeutic Nuclear Medicines Import and Export from 2014-2019E 11.6 Europe Therapeutic Nuclear Medicines Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Therapeutic Nuclear Medicines Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Therapeutic Nuclear Medicines by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Therapeutic Nuclear Medicines Sales by Country (2014-2019E) 11.8.2 Europe Therapeutic Nuclear Medicines Consumption Value by Country (2014-2019E) 11.9 Europe Therapeutic Nuclear Medicines Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Therapeutic Nuclear Medicines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Therapeutic Nuclear Medicines Production Analysis from 2014-2019E 12.4 Asia-Pacific Therapeutic Nuclear Medicines Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Therapeutic Nuclear Medicines Import and Export from 2014-2019E 12.6 Asia-Pacific Therapeutic Nuclear Medicines Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Therapeutic Nuclear Medicines Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Therapeutic Nuclear Medicines by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Therapeutic Nuclear Medicines Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Therapeutic Nuclear Medicines Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Therapeutic Nuclear Medicines Market PEST Analysis 13 Latin America 13.1 Latin America Therapeutic Nuclear Medicines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Therapeutic Nuclear Medicines Production Analysis from 2014-2019E 13.4 Latin America Therapeutic Nuclear Medicines Consumption Analysis from 2014-2019E 13.5 Latin America Therapeutic Nuclear Medicines Import and Export from 2014-2019E 13.6 Latin America Therapeutic Nuclear Medicines Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Therapeutic Nuclear Medicines Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Therapeutic Nuclear Medicines by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Therapeutic Nuclear Medicines Sales by Country (2014-2019E) 13.8.2 Latin America Therapeutic Nuclear Medicines Consumption Value by Country (2014-2019E) 13.9 Latin America Therapeutic Nuclear Medicines Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Therapeutic Nuclear Medicines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Therapeutic Nuclear Medicines Production Analysis from 2014-2019E 14.4 Middle East & Africa Therapeutic Nuclear Medicines Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Therapeutic Nuclear Medicines Import and Export from 2014-2019E 14.6 Middle East & Africa Therapeutic Nuclear Medicines Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Therapeutic Nuclear Medicines Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Therapeutic Nuclear Medicines by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Therapeutic Nuclear Medicines Market PEST Analysis 15 Future Forecast of the Global Therapeutic Nuclear Medicines Market from 2018-2026 15.1 Future Forecast of the Global Therapeutic Nuclear Medicines Market from 2019-2026 Segment by Region 15.2 Global Therapeutic Nuclear Medicines Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Therapeutic Nuclear Medicines Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Therapeutic Nuclear Medicines Market Value ($) and Growth Rate of Therapeutic Nuclear Medicines from 2014-2026 Global Therapeutic Nuclear Medicines Production and Growth Rate Segment by Product Type from 2014-2026F Global Therapeutic Nuclear Medicines Consumption and Growth Rate Segment by Application from 2014-2019E Figure Therapeutic Nuclear Medicines Picture Table Product Specifications of Therapeutic Nuclear Medicines Table Driving Factors for this Market Table Industry News of Therapeutic Nuclear Medicines Market Figure Value Chain Status of Therapeutic Nuclear Medicines Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Therapeutic Nuclear Medicines Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Therapeutic Nuclear Medicines Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Beta Emitters of Therapeutic Nuclear Medicines Figure Alpha Emitters of Therapeutic Nuclear Medicines Figure Brachytherapy Products of Therapeutic Nuclear Medicines Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Therapeutic Nuclear Medicines Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospitals of Therapeutic Nuclear Medicines Figure Ambulatory Surgical Centers of Therapeutic Nuclear Medicines Figure Radiology Clinics of Therapeutic Nuclear Medicines Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Therapeutic Nuclear Medicines Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Therapeutic Nuclear Medicines Figure Online Channel of Therapeutic Nuclear Medicines Table Advanced Accelerator Applications S.A. Profile (Company Name, Plants Distribution, Sales Region) Figure Advanced Accelerator Applications S.A. Sales and Growth Rate from 2014-2019E Figure Advanced Accelerator Applications S.A. Revenue ($) and Global Market Share from 2014-2019E Table Advanced Accelerator Applications S.A. Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table Nordion, Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Nordion, Inc. Sales and Growth Rate from 2014-2019E Figure Nordion, Inc. Revenue ($) and Global Market Share from 2014-2019E Table Nordion, Inc. Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table Eczacibasi-Monrol Nuclear Products Profile (Company Name, Plants Distribution, Sales Region) Figure Eczacibasi-Monrol Nuclear Products Sales and Growth Rate from 2014-2019E Figure Eczacibasi-Monrol Nuclear Products Revenue ($) and Global Market Share from 2014-2019E Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bayer AG Profile (Company Name, Plants Distribution, Sales Region) Figure Bayer AG Sales and Growth Rate from 2014-2019E Figure Bayer AG Revenue ($) and Global Market Share from 2014-2019E Table Bayer AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table GE Healthcare Profile (Company Name, Plants Distribution, Sales Region) Figure GE Healthcare Sales and Growth Rate from 2014-2019E Figure GE Healthcare Revenue ($) and Global Market Share from 2014-2019E Table GE Healthcare Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table Cardinal Health Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Cardinal Health Inc. Sales and Growth Rate from 2014-2019E Figure Cardinal Health Inc. Revenue ($) and Global Market Share from 2014-2019E Table Cardinal Health Inc. Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bracco Imaging S.p.A Profile (Company Name, Plants Distribution, Sales Region) Figure Bracco Imaging S.p.A Sales and Growth Rate from 2014-2019E Figure Bracco Imaging S.p.A Revenue ($) and Global Market Share from 2014-2019E Table Bracco Imaging S.p.A Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table Mallinckrodt plc. Profile (Company Name, Plants Distribution, Sales Region) Figure Mallinckrodt plc. Sales and Growth Rate from 2014-2019E Figure Mallinckrodt plc. Revenue ($) and Global Market Share from 2014-2019E Table Mallinckrodt plc. Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table IBA Molecular Imaging Profile (Company Name, Plants Distribution, Sales Region) Figure IBA Molecular Imaging Sales and Growth Rate from 2014-2019E Figure IBA Molecular Imaging Revenue ($) and Global Market Share from 2014-2019E Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table Lantheus Medical Imaging Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Lantheus Medical Imaging Inc. Sales and Growth Rate from 2014-2019E Figure Lantheus Medical Imaging Inc. Revenue ($) and Global Market Share from 2014-2019E Table Lantheus Medical Imaging Inc. Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Therapeutic Nuclear Medicines Production Value ($) by Region from 2014-2019E Table Global Therapeutic Nuclear Medicines Production Value Share by Region from 2014-2019E Table Global Therapeutic Nuclear Medicines Production by Region from 2014-2019E Table Global Therapeutic Nuclear Medicines Consumption Value ($) by Region from 2014-2019E Table Global Therapeutic Nuclear Medicines Consumption by Region from 2014-2019E Table North America Therapeutic Nuclear Medicines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Therapeutic Nuclear Medicines Import and Export from 2014-2019E Table North America Therapeutic Nuclear Medicines Value ($) by Type (2014-2019E) Table North America Therapeutic Nuclear Medicines Production by Type (2014-2019E) Table North America Therapeutic Nuclear Medicines Consumption by Application (2014-2019E) Table North America Therapeutic Nuclear Medicines Consumption by Country (2014-2019E) Table North America Therapeutic Nuclear Medicines Consumption Value ($) by Country (2014-2019E) Figure North America Therapeutic Nuclear Medicines Market PEST Analysis Table Europe Therapeutic Nuclear Medicines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Therapeutic Nuclear Medicines Import and Export from 2014-2019E Table Europe Therapeutic Nuclear Medicines Value ($) by Type (2014-2019E) Table Europe Therapeutic Nuclear Medicines Production by Type (2014-2019E) Table Europe Therapeutic Nuclear Medicines Consumption by Application (2014-2019E) Table Europe Therapeutic Nuclear Medicines Consumption by Country (2014-2019E) Table Europe Therapeutic Nuclear Medicines Consumption Value ($) by Country (2014-2019E) Figure Europe Therapeutic Nuclear Medicines Market PEST Analysis Table Asia-Pacific Therapeutic Nuclear Medicines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Therapeutic Nuclear Medicines Import and Export from 2014-2019E Table Asia-Pacific Therapeutic Nuclear Medicines Value ($) by Type (2014-2019E) Table Asia-Pacific Therapeutic Nuclear Medicines Production by Type (2014-2019E) Table Asia-Pacific Therapeutic Nuclear Medicines Consumption by Application (2014-2019E) Table Asia-Pacific Therapeutic Nuclear Medicines Consumption by Country (2014-2019E) Table Asia-Pacific Therapeutic Nuclear Medicines Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Therapeutic Nuclear Medicines Market PEST Analysis Table Latin America Therapeutic Nuclear Medicines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Therapeutic Nuclear Medicines Import and Export from 2014-2019E Table Latin America Therapeutic Nuclear Medicines Value ($) by Type (2014-2019E) Table Latin America Therapeutic Nuclear Medicines Production by Type (2014-2019E) Table Latin America Therapeutic Nuclear Medicines Consumption by Application (2014-2019E) Table Latin America Therapeutic Nuclear Medicines Consumption by Country (2014-2019E) Table Latin America Therapeutic Nuclear Medicines Consumption Value ($) by Country (2014-2019E) Figure Latin America Therapeutic Nuclear Medicines Market PEST Analysis Table Middle East & Africa Therapeutic Nuclear Medicines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Therapeutic Nuclear Medicines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Therapeutic Nuclear Medicines Import and Export from 2014-2019E Table Middle East & Africa Therapeutic Nuclear Medicines Value ($) by Type (2014-2019E) Table Middle East & Africa Therapeutic Nuclear Medicines Production by Type (2014-2019E) Table Middle East & Africa Therapeutic Nuclear Medicines Consumption by Application (2014-2019E) Table Middle East & Africa Therapeutic Nuclear Medicines Consumption by Country (2014-2019E) Table Middle East & Africa Therapeutic Nuclear Medicines Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Therapeutic Nuclear Medicines Market PEST Analysis Table Global Therapeutic Nuclear Medicines Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Therapeutic Nuclear Medicines Production and Growth Rate Forecast by Region (2019-2026) Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Therapeutic Nuclear Medicines Production and Growth Rate Forecast by Type (2019-2026) Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate Forecast by Application (2019-2026)